The landscape of treating Gastrointestinal Stromal Tumors has been fundamentally reshaped by the introduction of Targeted Therapy Innovations, moving the focus from traditional chemotherapy to molecularly driven medicine. These treatments specifically target the underlying genetic defects that drive tumor growth, primarily activating mutations in the c-KIT or PDGFRA tyrosine kinase receptors....
Turkish 
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt